We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

AI Tool Identifies Gene Combinations Causing Complex Illnesses

By LabMedica International staff writers
Posted on 11 Jun 2025

For years, scientists have faced significant challenges in decoding the genetic basis of complex diseases like diabetes, asthma and cancer. Traditional methods such as genome-wide association studies often fall short in identifying how multiple genes interact to influence these traits, primarily due to limited statistical power and the vast number of possible gene combinations. Now, researchers have developed a new computational tool that uses generative artificial intelligence (AI) to uncover the genetic networks driving complex human conditions.

The tool, known as Transcriptome-Wide Conditional Variational Auto-Encoder (TWAVE), was created by a team of biophysicists at Northwestern University (Evanston, IL, USA) to improve understanding of how combinations of genes contribute to disease development. This model represents a breakthrough in linking genotype to phenotype by shifting the analytical focus from individual genes to coordinated gene groups.

Image: The new method uses a generative AI model to amplify limited gene expression data (Photo courtesy of Camila Felix/Northwestern University)
Image: The new method uses a generative AI model to amplify limited gene expression data (Photo courtesy of Camila Felix/Northwestern University)

TWAVE uses a generative AI model that amplifies limited gene expression data to detect patterns of gene activity associated with disease states. It works by simulating both healthy and diseased cellular environments and identifying how specific changes in gene expression can alter those states. Through a combined machine learning and optimization framework, TWAVE pinpoints the gene changes most likely to transition a cell from healthy to diseased or vice versa.

By analyzing gene expression rather than DNA sequences, TWAVE circumvents patient privacy concerns and captures the influence of environmental factors that can modulate gene activity. This focus allows the model to provide a dynamic view of cellular function and better reflect the complexity of real-world disease mechanisms. In the study published in the PNAS, TWAVE was tested across a variety of complex diseases. It successfully identified relevant gene combinations, including some that had been missed by existing techniques.

Notably, the model revealed that the same disease could arise from different gene sets in different individuals, highlighting the potential for more personalized therapeutic strategies. By revealing gene networks instead of isolated markers, TWAVE offers a powerful tool for developing targeted treatments that consider the specific genetic drivers in each patient. It paves the way for new interventions designed to modify the collective gene expression patterns that underlie chronic and multifactorial diseases.

“Many diseases are determined by a combination of genes — not just one,” said Northwestern’s Adilson Motter, the study’s senior author. “You can compare a disease like cancer to an airplane crash. In most cases, multiple failures need to occur for a plane to crash, and different combinations of failures can lead to similar outcomes. This complicates the task of pinpointing the causes. Our model helps simplify things by identifying the key players and their collective influence.”


New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Automated Biochemical Analyzer
iBC 900

Latest Pathology News

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response
11 Jun 2025  |   Pathology

Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy
11 Jun 2025  |   Pathology

Saliva-Based Testing to Enable Early Detection of Cancer, Heart Disease or Parkinson’s
11 Jun 2025  |   Pathology



PURITAN MEDICAL